SEATTLE, June 21, 2018 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq:TRUP), a leading provider of medical insurance for cats and dogs,
announced today the pricing of its underwritten registered public offering of 1,818,182 shares of its common stock (“Common Stock”)
at a price to the public of $33.00 per share. Trupanion also granted the underwriters a 30-day option to purchase up to
272,727 additional shares of common stock. Closing of the offering is expected to occur on or about June 25, 2018, subject to
customary closing conditions. All of the shares sold in the offering are being sold by Trupanion. The gross proceeds to Trupanion
from this offering are expected to be approximately $60.0 million, before deducting underwriting discounts and commissions and
offering expenses payable by Trupanion.
Trupanion is seeking to reduce its fixed expenses and expand the funds available to invest in growth and drive other strategic
initiatives. Trupanion intends to use the net proceeds from the offering to fund the purchase of its home office building,
located in Seattle, WA. Trupanion believes the opportunity to own its building will reduce its fixed expenses, enabling
Trupanion to provide the best value proposition to its customers and fund additional investment in pet acquisition to continue to
grow the category. Additionally, a portion of the building may be owned by Trupanion’s insurance entity, freeing up
additional working capital to invest in growth and other strategic initiatives. Any remaining funds will be used for general
corporate purposes, including general and administrative expenses and capital expenditures.
Stifel is acting as the sole book-running manager for the offering. Canaccord, CL King & Associates, Lake Street and Northland
Capital Markets are acting as co-managers for the offering.
The offering of these securities will be made only by means of a registration statement (including a preliminary prospectus for
the offering) filed with the U.S. Securities and Exchange Commission on June 20, 2018. Copies of the preliminary prospectus
supplement and accompanying prospectus relating to these securities may be obtained by contacting Stifel, Nicolaus & Company,
Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, by calling (415) 364-2720
or by emailing syndprospectus@stifel.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Trupanion, nor
shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Trupanion
Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For almost two decades,
Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is
committed to providing pet owners with the highest value in pet medical insurance with unlimited payouts for the life of their
pets. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA.
Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in
Canada, by Omega General Insurance Company. For more information, please visit Trupanion.com.
Forward-Looking Statements
This press release includes statements relating to the proposed offering of our common stock. These statements and other statements
regarding our future plans and goals constitute “forward looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict,
are beyond our control, and which may cause results to differ materially from expectations and include our expectations regarding
the proposed offering and use of proceeds. These forward-looking statements are based upon the current expectations and
beliefs of Trupanion’s management as of the date of this press release and are subject to certain risks and uncertainties that
could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking
statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion has no
obligation to update these forward-looking statements
Contacts:
Investors
Laura Bainbridge, Addo Investor Relations
310.829.5400
InvestorRelations@trupanion.com
Media
Scott Janzen, Trupanion Director of Communications
scott.janzen@trupanion.com
888.612.1138 ext 3450
